Загрузка...

BIG PHARMA, FDA SAFETY & THE FIGHT OVER FLUOROQUINOLONE TOXICITY

BIG PHARMA, FDA SAFETY & THE FIGHT OVER FLUOROQUINOLONE TOXICITY

USA GLOBAL TV® & RADIO
PRESENTS
THIS IS FLOXED
HOSTED BY TALIA SMITH
FEATURING CHARLES L. BENNETT MD PHD MPP
19 MAY 2026
EPISODE 2026-08

DESCRIPTION
What happens when a physician takes on one of the largest pharmaceutical safety battles in the United States?

On this episode of THIS IS FLOXED, host Talia Smith welcomes nationally recognized physician-scientist Charles L. Bennett MD PhD MPP for a deep discussion about fluoroquinolone toxicity, pharmaceutical accountability, adverse drug reactions, and the ongoing legal and regulatory fight surrounding some of the most commonly prescribed antibiotics in the world.

Dr. Bennett is one of the nation’s leading experts in medication safety and efficacy and has spent decades researching adverse drug reactions through SONAR - the Southern Network on Adverse Reactions. His work helped uncover serious neurological and psychiatric risks associated with fluoroquinolone antibiotics including Levofloxacin, Moxifloxacin, and Ciprofloxacin.

The conversation will explore:
The long-term impact of fluoroquinolone adverse events
FDA safety warnings and international regulatory actions
The role of pharmaceutical watchdog research
Drug safety transparency and accountability
The legal battle involving allegations of “fraud on the FDA”
What patients, physicians, and families need to understand moving forward

ABOUT CHARLES L. BENNETT MD PHD MPP
Charles L. Bennett MD PhD MPP is the Frank P. and Jose M. Fletcher Chair of Medication Safety and Efficacy at the University of South Carolina College of Pharmacy and an Affiliate Investigator with the Johns Hopkins Bloomberg School of Public Health Drug Access and Affordability Initiative.
Dr. Bennett is one of the nation’s foremost experts in pharmaceutical safety research and adverse drug reactions. He leads SONAR - the Southern Network on Adverse Reactions - a nationally recognized pharmaceutical watchdog program that partners closely with members of the Floxie community.

Dr. Bennett was the sole plaintiff in U.S. ex rel. Bennett v. Bayer Corporation, a landmark case involving allegations that pharmaceutical manufacturers failed to fully disclose safety data related to permanent neurological and psychiatric toxicity associated with fluoroquinolone antibiotics.

His research contributed to FDA safety actions and international regulatory reviews involving fluoroquinolone toxicity in the United States, Canada, the European Union, Japan, Australia, and the United Kingdom.

Over the course of his career, Dr. Bennett has led more than $25 million in peer-reviewed research funding and has published more than 500 peer-reviewed manuscripts, including publications in The New England Journal of Medicine, The Lancet, JAMA, and Health Affairs.

CONTACT CHARLES L. BENNETT MD PHD MPP
Email:
Bennett@cop.sc.edu
Book:
Taking on Big Pharma: Dr. Bennett’s Battle

ABOUT TALIA SMITH
Talia Smith is the host of THIS IS FLOXED on USA GLOBAL TV® & RADIO. Through deeply personal and investigative conversations, Talia provides a platform for individuals impacted by fluoroquinolone toxicity while bringing awareness to patient advocacy, medical safety, chronic illness, and the long-term consequences many people face after adverse pharmaceutical reactions.

SUBSCRIBE:
https://www.youtube.com/c/usaglobaltv
https://www.youtube.com/@drjacalynkerbeck

FOLLOW:
https://www.instagram.com/usa_global_tv__radio/
https://www.instagram.com/dr.jacalyn/

#ThisIsFloxed #FluoroquinoloneToxicity #MedicationSafety #DrugSafety #BigPharma #FDA #CharlesBennett #TaliaSmith #AdverseDrugReactions #PatientAdvocacy #Healthcare #MedicalResearch #USAGlobalTV #Floxed #TheListeningMentor

Видео BIG PHARMA, FDA SAFETY & THE FIGHT OVER FLUOROQUINOLONE TOXICITY канала USA GLOBAL TV ® & RADIO
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять